It is uncertain what effect suppressive antiretroviral therapy (ART) (HIV-RNA<50 copies/mL) has on the results of CIN2+ treatment among women living with HIV (WLWH). We conducted a matched register-based national cohort study with the aim of analyzing: 1) if WLWH in Sweden have a poorer outcome after treatment of CIN2+ than HIV-negative women 2) to identify predictors of CIN2+ treatment failure and recurrence.
The Swedish National HIV Registry and the Swedish Population Registry were linked with the Swedish National Cervical Screening Registry. We identified all WLWH, living in the Counties of Stockholm and Gothenburg sometime between 1983 and 2014, with a diagnosis of cervical intraepithelial neoplasia grade 2 or worse (CIN2+). For each WLWH we randomly selected two HIV-negative women, living in the same counties sometime between 1983 and 2014, diagnosed with CIN2+, matched for country of birth. Additional data, such as surgical method, was collected from medical records. Treatment failure was defined as the presence of an abnormal cervical cytology/histology at initial follow-up. Recurrence was defined as the presence of CIN1+ subsequent to an initial normal follow-up. Logistic regression and Cox regression were used to estimate the effect of predictors of treatment failure and recurrence respectively. All models were adjusted for age and birth region.
A total of 140 WLWH and 284 HIV-negative women were treated for CIN2+ and had at least one follow-up cervical cytology/histology within one year and were not treated with a hysterectomy. WLWH were three times more likely to have a treatment failure (odds ratio (OR) 3.3 (95% CI 2.1-5.2) and five times more likely to recur (hazard ratio 5.0 (95% CI 2.1-11.6) than HIV-negative women. Suppressive ART at time of treatment of CIN2+ was associated with reduced odds of treatment failure (OR 0.4 (95% CI 0.2-0.8)). Advanced immunosuppression (CD4+T-cell/μL<200) at time of treatment of CIN2+ was associated with almost nine times higher odds of treatment failure than a CD4 count ≥500 (OR 8.9 (95% CI 2.9-27.7).
To our knowledge this is the first study to show that suppressive ART and CD4 counts ≥500 at time of treatment are both associated with an effective treatment of CIN2+. An early HIV diagnosis, immediate ART and continuum of care are all essential to reach successful CIN2+ treatment.